Hippo pathway

阻害剤の選択性比較

カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S1786 Verteporfin <1 mg/mL 100 mg/mL <1 mg/mL
S8334 XMU-MP-1 <1 mg/mL 83 mg/mL <1 mg/mL
S8554 Super-TDU 100 mg/mL -1 mg/mL -1 mg/mL
S8164 YAP-TEAD Inhibitor 1 (Peptide 17) 100 mg/mL -1 mg/mL -1 mg/mL
S8661 CA3 <1 mg/mL 97 mg/mL <1 mg/mL

Hippo pathway製品

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1786

Verteporfin

Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent derived from porphyrin.

S8334

XMU-MP-1

XMU-MP-1 is an inhibitor of MST1/2 with IC50 values of 71.1±12.9 nM and 38.1±6.9 nM against MST1 and MST2, respectively.

S8554

Super-TDU

Super-TDU is an inhibitory peptide targeting YAP-TEADs interaction.

S8164

YAP-TEAD Inhibitor 1 (Peptide 17)

Peptide 17 is a YAP-TEAD protein-protein interaction inhibitor which has potential usage in treatment of YAP-involved cancers with IC50 of 25 nM.

S8661

CA3

CA3 has potent inhibitory effects on YAP1/Tead transcriptional activity and primarily targets YAP1 high and therapy-resistant esophageal adenocarcinoma cells endowed with CSC properties.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1786

Verteporfin

Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent derived from porphyrin.

S8334

XMU-MP-1

XMU-MP-1 is an inhibitor of MST1/2 with IC50 values of 71.1±12.9 nM and 38.1±6.9 nM against MST1 and MST2, respectively.

S8554

Super-TDU

Super-TDU is an inhibitory peptide targeting YAP-TEADs interaction.

S8164

YAP-TEAD Inhibitor 1 (Peptide 17)

Peptide 17 is a YAP-TEAD protein-protein interaction inhibitor which has potential usage in treatment of YAP-involved cancers with IC50 of 25 nM.

S8661

CA3

CA3 has potent inhibitory effects on YAP1/Tead transcriptional activity and primarily targets YAP1 high and therapy-resistant esophageal adenocarcinoma cells endowed with CSC properties.

Tags: Hippo signaling pathway | Hippo pathway | Hippo pathway inhibitor review
×

大阪市内で「G20サミット」が開催されることに伴い、大阪府内で大規模な交通規制が行われる影響で、6月26日(水)から7月1日(月)までの間、下記地域へ出荷が行えなくなります。
対象地域
大阪府(全域)、兵庫県(芦屋市、尼崎市、伊丹市、西宮市)
上記地域より西の地域につきましては納期の遅延が予想されます。
また、国際便も遅延が予想されているため国内在庫がない製品の納期が一週間程度遅れる可能性がございます。
ご不便をおかけいたしますが、宜しくお願い申し上げます。